Product Description
Mechanisms of Action: G-Secretase Modulator
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Hoffmann-La Roche
Company Location: BASEL SWITZERLAND V8
Company CEO: Severin Schwan
Additonal Commercial Interests: None
Clinical Description
![Map of Global Clinical Trials for RO-7269162](https://pryzm-maps.s3.us-west-2.amazonaws.com/9135current_maps.png)
Countries in Clinic: Denmark, France, Germany, Italy, Korea, Poland, Spain